Press releases

MENLO PARK, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) — PacBio announced today that its executives will be speaking at the following investor conferences: Stifel 2021 Virtual Healthcare Conference on November…

MENLO PARK, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2021. Record revenue reflects 6th straight quarter of…

Leading Global Genomics and Diagnostic Testing Firm Adds More Comprehensive Genetic Information to its Services MENLO PARK, Calif. and HONG KONG, Nov. 02, 2021 (GLOBE NEWSWIRE) — PacBio will be…

MENLO PARK, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its third quarter 2021 financial results…

Partnership to Improve Biodiversity Research, Accelerate Conservation with Actionable and Accurate Genomic Data MENLO PARK, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences”…

MENLO PARK, Calif., Sept. 24, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing platforms, today announced…

Omniome’s High Accuracy Short-Read Sequencing Platform Expected to Significantly Expand PacBio’s Market Opportunity. Acquisition Expected to Accelerate the Adoption of SMRT Sequencing, PacBio’s Leading Long-Read Sequencing Platform. PacBio Also Closes…

MENLO PARK, Calif., Sept. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: Wells…

MENLO PARK, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conference: UBS…

MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2021. Record second quarter…

Technology Will Enable Continued End-to-End Automated Workflow Development MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading…

MENLO PARK, Calif., July 28, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing platforms, today announced…

Collaboration to develop production-scale HiFi Sequencing platformexpected to Include technology from Omniome, Inc. Combining both highly accurate long and short read sequencing technologies expected to provide deeper clinical insights and…

Combination aims to transform the genomics landscape and deliver a differentiated product offering into high growth clinical markets Brings together Omniome’s high accuracy short-read sequencing platform, with PacBio’s market leading,…

MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its second quarter 2021 financial results…